Trailing-twelve-month (TTM) revenue is $2.79 Million with a year-over-year growth of (94.63%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $966,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $620,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-05 |
| Q1 FY2026Period ended 2026-03-31 | $696,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $507,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $2,789,000 |
Current P/S: $265,776,915 market capitalization ÷ $2,789,000 TTM revenue = 95.29x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $507000.00.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:06:48.716Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20242024-12-31 · USD |
|---|---|---|---|---|---|
| D E X Y C U Product | $5M | $7M | $18M | $12M | N/A |
| License And Collaboration Agreement | N/A | N/A | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20182018-06-30 · USD | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20242024-12-31 · USD |
|---|---|---|---|---|---|---|
| CHINA | N/A | $1M | $12M | $851,000 | $823,000 | $1M |
| UNITED STATES | $3M | $19M | $23M | $36M |
$2.79M
$2.79 Million
(94.63%)
vs. $51.94M a year ago (TTM)
(41.05%)
5 Year compound annual growth rate
1 Year
(94.63%)
3 Year
(57.88%)
5 Year
(41.05%)
10 Year
+5.58%
15 Year
(3.77%)
20 Year
+7.41%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $31.37M | ($11.90M) | (27.50%) |
| 2024 | $43.27M | ($2.75M) | (5.97%) |
| 2023 | $46.02M | +$4.61M | +11.14% |
| 2022 | $41.40M | +$4.46M | +12.09% |
| 2021 | $36.94M | +$2.50M | +7.27% |
| 2020 |
TTM Growth
(94.63%)
3-Year CAGR
(57.88%)
5-Year CAGR
(41.05%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T21:06:48.716Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| Product | N/A | N/A | N/A | N/A | $3M |
|---|
| Royalty | N/A | N/A | N/A | N/A | $2M |
|---|
| Y U T I Q Product | $12M | $14M | $17M | $28M | $3M |
|---|
| $40M |
| $42M |
| $34.44M |
| +$14.07M |
| +69.10% |
| 2019 | $20.36M | +$14.51M | +247.76% |
| 2018 | $5.86M | +$2.90M | +97.77% |
| 2017 | $2.96M | ($4.58M) | (60.72%) |
| 2016 | $7.54M | +$5.92M | +365.37% |
